ABSTRACT. Our study was undertaken to examine the pharmacological and biological effects of tin-protoporphyrin, a competitive inhibitor of heme oxygenase, on 5-or 6-day-old homozygous Cjlj) Gunn rats with hereditary unconjugated hyperbilirubinemia. When j / j neonates were injected subcutaneously with 20 pmol of tin-protoporphyrintkg of body weight, hepatic heme oxygenase activity decreased to 30% of the initial level 2 h after administration and remained low during the next 46 h. However, the reduction of serum bilirubin was more rapid and transient, reaching the minimum value (40% of the initial level) at 1 h and increasing thereafter at a rate almost comparable to that in nontreated j/j rats. The mortality rate of j / j rats was strikingly reduced by the administration of 1 to 100 pmol of tin-protoporphyrin/kg; the most effective dose was 5 pmol/kg (8% compared with 80% in non-treated j/j rats). However, the protective effect of tin-protoporphyrin on bilirubin cerebellopathy (cerebellar hypoplasia) was less marked than expected. Possible implications of our results are discussed. (Pediatr Res 24: 209-912, 1988) 
rates developing hyperbilirubinemia in newborn rats (4, 5) and rhesus monkeys (6) and reduces the plasma bilirubin level in adult mutant mice with hemolytic anemia (7, 8) . j/j Gunn rats with an inherited deficiency of hepatic bi1irubin:uridine diphosphate-glucuronyltransferase activity (9) are hyperbilirubinemic throughout life (10) and develop bilirubin-induced cerebellar hypoplasia (1 1-14) . In our study we evaluated the pharmacological and biological effects of SnPP in this rat model of neonatal jaundice.
MATERIALS AND METHODS
j/j and apparently normal j/+ Gunn rats of the SpragueDawley strain, developed in our laboratory (14) , were used in our study. The breeding conditions were as reported previously (1 4) . The litter size was restricted to eight pups soon after delivery. SnPP was purchased from Porphyrin Products (Logan, UT). All other chemicals used were of the highest grade commercially available. SnPP was dissolved in a small volume of 0.1 N KOH, the pH was adjusted to 7.4 with 0.1 N HCl, and the solution was diluted to desired concentrations with 0.1 M phosphate buffer, pH 7.4. All solutions were prepared under dim light just before use. SnPP was administered subcutaneously to j/j and j/+ rats at various doses up to 100 pmol/kg of body weight.
Treated and nontreated adult rats were anesthetized with chloroform and perfused in situ with ice-cold physiological saline. Livers and spleens were excised and homogenized in a Teflon-pestled glass homogenizer with 3 vol of 50 mM Tris-C1 buffer, pH 7.4, containing 0.25 M sucrose. The homogenate was centrifuged at 18,000 x g for 10 min. The supernatants from the livers and spleens of j/+ rats, and from the spleens of j/j rats were used to assess the kinetic parameters of heme oxygenase. In the case of the j/j rat livers, the microsomal fraction was analyzed because of a very high concentration of bilirubin in the 18,000 x g supernatant. The microsomal pellet, obtained by centrifuging the supernatant at 105,000 x g for 60 min, was resuspended in 50 mM Tris-C1 buffer, pH 7.4, containing 0.25 M sucrose.
Heme oxygenase activity was measured by the method of
Tenhunen et al. (1 5 Bilirubin extracted was calculated from the difference between absorbances at 452 and 520 nm by using a molecular extinction coefficient at 452 nm of 62,600 (17) . All procedures were carried out under dim light. The amount of bilirubin formed was linear with respect to incubation time or protein concentration under the conditions used. The specific activity was expressed as nmol of bilirubin formedlmg of protein/ 10 min. Protein was estimated by the method of Lowry et al. (1 8) using crystalline bovine serum albumin as a standard. The total serum bilirubin concentration was determined according to the method of Malloy and Evelyn (19) . Group mean comparisons were made by the t test or alternatively a modified t test (the Cochran and Cox method) when group variances were unequal. Figure 1 shows representative double reciprocal plots of splenic heme oxygenase activity versus methemalbumin (substrate) with and without SnPP in adult j/+ rats. The two lines converged to almost the same point on the ordinate, which is consistent with previous reports that SnPP is a competitive inhibitor with respect to the substrate (4, 5) . Apparent Km values for methemalbumin were calculated to be 33.4 and 7.3 +M in the presence and absence of the inhibitor, respectively. Table 1 summarizes kinetic parameters obtained from four separate experiments with enzyme preparations from the spleen and liver of j/+ and j/j adult rats. The competitive nature of SnPP inhibition with regard to the substrate was common in all cases. Although some variations were observed in Km values for the substrate among four enzyme sources, they were not greatly different from each other. This was also true of apparent inhibition constants (Ki) for SnPP.
RESULTS
As shown in Figure 2 , hepatic heme oxygenase activity in j/j neonates decreased rapidly after administration of SnPP to a minimum value, 2 h later. Enzyme activity increased gradually thereafter to about two-fifths of the initial level at 48 h. The response of serum bilirubin to SnPP is demonstrated in Figure  3 . Reduction in the concentration of serum bilirubin was rapid and transient. One h after SnPP treatment the bilirubin level decreased about 60% but increased steadily thereafter at a rate comparable to that in nontreated j/j rats. Various doses of SnPP (0.5-100 pmol/kg of body weight) were tested to evaluate in vivo effects on the rate of mortality and cerebellar development in jaundiced neonates. As shown in Table  2 there were no differences between the morality rates of SnPPtreated and nontreated j/+ rats. However, mortality was reduced in j/j rats injected with 1 to 100 pmol of SnPP/kg of body weight. The most effective dose was 5 pmol/kg of body weight. Although the cerebellar wet weight of any group of j/+ rats treated with SnPP did not differ significantly from that of the nontreated control group, the cerebellar weights of the j/j rat groups given 1 and 5 pmol of drug/kg were significantly increased (by 5 1 and 45%, respectively) over the control value (Table 2) . DISCUSSION The present kinetic study demonstrates that heme oxygenases prepared from liver and spleen have similar affinity for heme or SnPP between in the j/+ and j/j Gunn rats. The apparent Km values for heme of hepatic and splenic enzymes were within the range reported previously for microsomal preparations from human (4) and rat (15) spleens, or rat liver (5). The Ki values for SnPP also were similar to values in previous reports (4, 5) . Thus the heme oxygenase characteristics in liver and spleen were similar in nature independent of genotype.
As shown in several in vivo studies (4) (5) (6) (7) (8) , the administration of SnPP to j/j neonates causes rapid decreases in hepatic heme oxygenase activity and serum bilirubin. However, the reduction of serum bilirubin occurred within 60 min after SnPP administration, whereas the decrease in hepatic heme oxygenase activity continued for 2 h with a trend similar to that reported by Anderson et al. (20) . This is also recognized in the data reported previously (2 1-23) . Furthermore, the recovery of serum bilirubin was much faster than that of enzymatic activity. It has been reported that the biological half-life of bilirubin in j/j Gunn rats is 33 to 62 h (24) . Accordingly, even if heme oxygenase activity is completely blocked in vivo by SnPP, the serum bilirubin level would be expected to decrease more gradually than we observed.
There are several possible explanations about the observed phenomenon. SnPP may interfere with the bilirubin measurement. To assess this possibility, SnPP was mixed with the j/j rat serum at various concentrations (1-50 pM), and bilirubin assayed as described in "Materials and Methods." No interference * Various doses of SnPP were injected subcutaneously to 5-day-old j/ + a n d j/j G u n n rats a n d the effects of SnPP were examined a t 30 days of life. p < 0.0 1 compared with nontreated j/j rats. was observed (data not shown). Alternatively there could be a preferential effect of SnPP in nonhepatic tissues such as spleen and kidney. However, Anderson et al. (20) reported that SnPP administered intravenously accumulates in liver, spleen, and kidney with similar time-course profiles up to at least 12 h, and 1-h levels of the inhibitor in these tissues are far larger than the Ki value. These authors also showed that heme oxygenase activities in liver, spleen, and kidney are inhibited in the same timedependent manner by SnPP administered subcutaneously.
Another possibility is that there are heme degradation pathways not mediated by heme oxygenase (25) and that unconjugated bilirubin may be catabolized by mixed-function monooxygenases (26) . We cannot exclude an effect of SnPP to stimulate these pathways and accelerate the reduction of serum bilirubin. SnPP could be acting as a photosensitizer to enhance bilirubin destruction (27) . This appears unlikely because the present experiments, including the assay for bilirubin, were performed under dim light. Finally, SnPP may act to displace bilirubin from the albumin-bilirubin complex and cause pigment deposition in tissues with a concomitant decrease of serum levels. Recently Breslow et al. (28) reported that the albumin-bilirubin binding is little affected by SnPP. However, they conducted their experiments in an in vitro system and it is not clear if the same is also true in vivo, particularly in hyperbilirubinemic Gunn rats.
Keino et al. (14) showed that the cerebellar hypoplasia of j/j rats could be prevented by photoirradiation from postnatal day 5 to 10 and that this photo-effect was due to the reduction of serum bilirubin. Unlike phototherapy, the protective effect of SnPP (in a single dose of 20 pmol/kg) on the cerebellar hypoplasia was relatively limited (15% increase over the control; Table  2 ), although a significant response of serum bilirubin to SnPP was observed (Fig. 3) . This contradiction may be explained by the long biological half-life of bilirubin in j/j rats (24) . Surprisingly the mortality rate o f j l j infants was most effectively reduced by the administration of SnPP at a dose of 5 pmol/kg of body weight (Table 2 ) and one-fifth of this dose also was effective in minimizing cerebellar hypoplasia ( Table 2 ). The mechanism for the SnPP-induced decrease in mortality rate with only a limited effect on the cerebellar hypoplasia remains unclear.
